Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Centogene N.V. - Common Shares (NQ:CNTG)

0.3250 UNCHANGED
Last Price Updated: 4:00 PM EDT, Aug 7, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.3250
Bid (Size) 0.3500 (12)
Ask (Size) 0.3730 (1)
Prev. Close 0.3250
Today's Range 0.3250 - 0.3250
52wk Range N/A - N/A
Shares Outstanding 27,595,835
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
CENTOGENE Closes Strategic Transaction with Private Equity Group Charme Capital Partners
From Centogene NV
Via GlobeNewswire
News headline image
CENTOGENE Announces Voting Results of Extraordinary General Meeting
Approval of All Resolutions, Including Announced Transaction With Charme Capital Partners 
From Centogene NV
Via GlobeNewswire

Performance

More News

Read More
News headline image
CENTOGENE Signs Strategic Transaction With Private Equity Group Charme Capital Partners
From Centogene NV
Via GlobeNewswire
News headline image
CENTOGENE Data on Novel Genetic Risk Factor for Parkinson’s Disease in The Lancet Neurology
From Centogene NV
Via GlobeNewswire
News headline image
CENTOGENE Receives Delisting Notice From Nasdaq
From Centogene NV
Via GlobeNewswire
News headline image
CENTOGENE Publication in Brain Journal Reveals 15% of Parkinson’s Disease Cases Are Linked to Genetic Factors
From Centogene NV
Via GlobeNewswire
News headline image
C-Path and CENTOGENE MOU to Enhance Collaboration in Lysosomal Disease Research and Drug Development
From Centogene NV
Via GlobeNewswire
News headline image
CENTOGENE Announces Adoption of All Resolutions Tabled at 2024 Annual General Meeting
From Centogene NV
Via GlobeNewswire
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗
Via InvestorPlace
News headline image
CENTOGENE Reports Full Year 2023 Financial Results and Recent Business Highlights
From Centogene NV
Via GlobeNewswire
News headline image
CENTOGENE Secures Approx. $20 Million to Strengthen Cash Position
From Centogene NV
Via GlobeNewswire
News headline image
CENTOGENE and Evotec Discover Promising New Molecule to Treat Gaucher Disease
From Centogene NV
Via GlobeNewswire
News headline image
CENTOGENE Biodatabank Grows to Incorporate Disease Insights From Over 850,000 Diverse Patients
From Centogene NV
Via GlobeNewswire
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗
Via InvestorPlace
News headline image
Why Wang & Lee Group Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga
News headline image
CENTOGENE Receives Nasdaq Non-Compliance Notice
From Centogene NV
Via GlobeNewswire
News headline image
CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disorders
From Centogene NV
Via GlobeNewswire
News headline image
CENTOGENE Collaborates on Research Published in Science Showing Immunopathological Landscape of Human Pre-TCRα Deficiency
From Centogene NV
Via GlobeNewswire
News headline image
CENTOGENE Announces Receipt of Nasdaq Notice of Delisting and Intention to Request a Hearing
From Centogene NV
Via GlobeNewswire
News headline image
CENTOGENE Explores Strategic Alternatives
From Centogene NV
Via GlobeNewswire
News headline image
CENTOGENE and the Laboratory of Human Genetics of Infectious Diseases at Institut Imagine Announce Rare Disease Research Collaboration
From Centogene NV
Via GlobeNewswire
News headline image
CENTOGENE Receives French Research Tax Credit Accreditation
From Centogene NV
Via GlobeNewswire
News headline image
CENTOGENE and The Michael J. Fox Foundation Announce Research Project to Validate Genetic Risk Factors of Parkinson’s Disease Using Multiomics
From Centogene NV
Via GlobeNewswire
News headline image
CENTOGENE Announces Preliminary Full Year 2023 Revenue
From Centogene NV
Via GlobeNewswire
News headline image
CENTOGENE Announces Voting Results of Extraordinary General Meeting
From Centogene NV
Via GlobeNewswire

Frequently Asked Questions

Is Centogene N.V. - Common Shares publicly traded?
Yes, Centogene N.V. - Common Shares is publicly traded.
What exchange does Centogene N.V. - Common Shares trade on?
Centogene N.V. - Common Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Centogene N.V. - Common Shares?
The ticker symbol for Centogene N.V. - Common Shares is CNTG on the Nasdaq Stock Market
What is the current price of Centogene N.V. - Common Shares?
The current price of Centogene N.V. - Common Shares is 0.3250
When was Centogene N.V. - Common Shares last traded?
The last trade of Centogene N.V. - Common Shares was at 08/07/24 04:00 PM ET
What is the market capitalization of Centogene N.V. - Common Shares?
The market capitalization of Centogene N.V. - Common Shares is 8.97M
How many shares of Centogene N.V. - Common Shares are outstanding?
Centogene N.V. - Common Shares has 9M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

© Copyright 2015, Penticton Herald, Penticton, BC. Powered by BLOX Content Management System from TownNews.com.